Cartier L, Araya F, Castillo J L, Zaninovic V, Hayami M, Miura T, Imai J, Sonoda S, Shiraki H, Miyamoto K
Department of Neurology, Faculty of Medicine, University of Chile, Santiago.
Jpn J Cancer Res. 1993 Jan;84(1):1-3. doi: 10.1111/j.1349-7006.1993.tb02774.x.
To clarify the real distribution of HTLV-I and -II carriers among indigenous people in central and South America, blood samples collected from indigenous people in isolated regions of Southern Chile were examined. Among 199 inhabitants from Chiloe Island and Pitrufquen town, three cases (1.5%) showed positive anti-HTLV-I antibodies. Two out of the three (82-year-old male and 58-year-old female) reacted to HTLV-II-specific Gag and/or Env proteins but not to HTLV-I-specific ones. The latter case was confirmed as an HTLV-II carrier by polymerase chain reaction test.
为了阐明人类嗜T淋巴细胞病毒I型(HTLV-I)和II型(HTLV-II)携带者在中美洲和南美洲原住民中的实际分布情况,对从智利南部偏远地区的原住民采集的血样进行了检测。在来自奇洛埃岛和皮特鲁夫肯镇的199名居民中,有3例(1.5%)抗HTLV-I抗体呈阳性。其中2例(82岁男性和58岁女性)对HTLV-II特异性Gag和/或Env蛋白有反应,但对HTLV-I特异性蛋白无反应。后一例通过聚合酶链反应检测被确认为HTLV-II携带者。